REQUEST A DEMO
Total
USD $0.00
Search more companies

Balkanpharma Dupnitsa AD (Bulgaria)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Balkanpharma - Dupnitsa AD Profile Updated: September 08, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Balkanpharma Dupnitsa is a subsidiary of Bulgaria's largest pharmaceuticals group Actavis AD, former Balkanpharma Holding. The drug maker, which produces over 150 types of medicines, is the country's largest producer of solid dose pharmaceuticals - both capsules and tablets.
In 1999, Balkanpharma, now part of the Icelandic generic drug group Actavis (former Pharmaco), bought 55% in the Dupnitsa-based plant for USD 11 million and pledged to invest USD 15.52 million in it over the next five years.
The main products of the company are Fezam, Sedalgin neo, Spazmalgon, Nifedipin, Atsetizal, Izodinit.

Headquarters
Samokovsko Shose 3
Dupnitsa; Kyustendil; Postal Code: 2600

Contact Details: Purchase the Balkanpharma Dupnitsa AD report to view the information.

Website: https://www.teva.bg/

Basic Information
Total Employees:
Purchase the Balkanpharma Dupnitsa AD report to view the information.
Outstanding Shares:
Purchase the Balkanpharma Dupnitsa AD report to view the information.
Registered Capital:
Purchase the Balkanpharma Dupnitsa AD report to view the information.
Financial Auditors:
Purchase the Balkanpharma Dupnitsa AD report to view the information.
Incorporation Date:
September 11, 1991
Key Executives
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
98.05%
Purchase this report to view the information.
0.33%
Purchase this report to view the information.
0.02%
Purchase this report to view the information.
0.02%
Company Performance
Financial values in the chart are available after Balkanpharma Dupnitsa AD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
-1.99%
Total operating revenue
-2.99%
Net Profit (Loss) for the Period
-4.85%
Total assets
9.22%
Total equity
4.21%
Net Profit Margin
-0.2%
Return on Equity (ROE)
-0.38%
Quick Ratio
-1.11%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?